Latest News and Press Releases

Want to stay updated on the latest news?

Sign into Reader Account Create Reader Account

January 25, 2022 05:06 ET | Source: Shanghai Ark Biopharmaceutical Co., Ltd.

爱科百发宣布完成抗呼吸道合胞病毒新药齐瑞索韦的III期临床试验全部患者入组和用药治疗

SHANGHAI, China, Jan. 25, 2022 (GLOBE NEWSWIRE) --...
January 25, 2022 05:06 ET | Source: Shanghai Ark Biopharmaceutical Co., Ltd.

ArkBio Announces Completion of Patient Enrollment and Dosing in AIRFLO, a Phase III Registration Trial of Ziresovir for Treatment of Respiratory Syncytial Virus Infection

SHANGHAI, China, Jan. 25, 2022 (GLOBE NEWSWIRE) -- On January 25, 2022, Shanghai Ark Biopharmaceutical Co., Ltd. (ArkBio) announced the completion of patient enrollment and dosing of ziresovir...